Evidence map›Paper›PMID 40935856›Full record

ReviewNature medicine2025

Health impacts of microplastic and nanoplastic exposure.

Marja H Lamoree, Jeske van Boxel, Federica Nardella, Kas J Houthuijs, Sicco H Brandsma, Frederic Béen, Majorie B M van Duursen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Update on environmental determinants of allergic diseases.The Journal of allergy and clinical immunology · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Microplastics, nanoplastics and liver disease: an emerging health concern?Nature reviews. Gastroenterology & hepatology · 2026
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marja H LamoreeAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. marja.lamoree@vu.nl.ORCID http://orcid.org/0000-0002-7373-7738
Jeske van BoxelAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0003-0318-1356
Federica NardellaAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Kas J HouthuijsAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-8205-2896
Sicco H BrandsmaAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Frederic BéenAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Majorie B M van DuursenAmsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As evidence demonstrating the presence of micro- and nanoplastics (MNPs) in the human body accumulates, so do concerns about their potential health impacts. Multiple factors determine the properties and behavior of MNPs-including polymer type, size, shape and the presence of a biocorona, among others-which place high demands on analytical methodology and tools for assessment of potential adverse health effects. Experimental models have shown that MNPs can cross cell barriers in the human lung and intestine and reach systemic circulation and subsequently tissues such as reproductive organs, placenta and brain. Early clinical findings indicate that MNPs may be associated with adverse health outcomes, including immune modulation, reproductive effects and cardiovascular effects. However, these studies typically suffer from low patient numbers and inadequate MNP exposure assessment, which precludes adequate risk assessment. Still, outcomes from animal and cell-based analyses generally support the preliminary clinical findings. To conduct more robust human studies, maturation of methods for exposure and effect assessment are crucial. Addressing these challenges will improve scientific research on the health impact of MNPs, which is urgently needed.

Indexed as

Environmental ExposureMicroplasticsNanoparticlesAnimalsFemaleHumansPregnancyRisk AssessmentMicroplastics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.